MedPath

TRIMO SAN

Trimo San

Approved
Approval ID

1e4a1caa-e6ba-44ef-8347-07e6385a7c9e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 17, 2022

Manufacturers
FDA

CooperSurgical, Inc.

DUNS: 801895244

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxyquinoline Sulfate and Sodium Lauryl Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59365-5030
Product Classification
G
Generic Name
Oxyquinoline Sulfate and Sodium Lauryl Sulfate
Product Specifications
Route of AdministrationVAGINAL
Effective DateJune 16, 2022
FDA Product Classification

INGREDIENTS (6)

SODIUM LAURYL SULFATEActive
Quantity: 0.1 mg in 1 g
Code: 368GB5141J
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
TROLAMINEInactive
Code: 9O3K93S3TK
Classification: IACT
OXYQUINOLINE SULFATEActive
Quantity: 0.25 mg in 1 g
Code: 61VUG75Y3P
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRIMO SAN - FDA Drug Approval Details